1. Costa, Roberta, Rodia, Maria Teresa, Pacilio, Serafina, Angelini, Corrado, Cenacchi, Giovanna. 2022. LGMD D2 TNPO3-Related: From Clinical Spectrum to Pathogenetic Mechanism. In Frontiers in neurology, 13, 840683. doi:10.3389/fneur.2022.840683. https://pubmed.ncbi.nlm.nih.gov/35309568/
2. Megarbane, Andre, Bizzari, Sami, Deepthi, Asha, Delague, Valérie, Urtizberea, J Andoni. . A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort. In Journal of neuromuscular diseases, 9, 193-210. doi:10.3233/JND-210652. https://pubmed.ncbi.nlm.nih.gov/34602496/
3. Pan, Xiaojuan, Huang, Bo, Ma, Qiang, Wang, Yongquan, Xiao, Bin. . Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA. In Clinical and translational medicine, 12, e994. doi:10.1002/ctm2.994. https://pubmed.ncbi.nlm.nih.gov/35876041/
4. Iwanami, Norimasa, Richter, Andreas S, Sikora, Katarzyna, Boehm, Thomas. 2023. Tnpo3 controls splicing of the pre-mRNA encoding the canonical TCR α chain of iNKT cells. In Nature communications, 14, 3645. doi:10.1038/s41467-023-39422-4. https://pubmed.ncbi.nlm.nih.gov/37339974/
5. Gao, Min, Hou, Liangchao, Zhang, Kaihui, Gai, Zhongtao, Liu, Yi. . [Analysis of TNPO3 gene variant and clinical phenotype in a neonate with limb-girdle muscular dystrophies form 1F]. In Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 39, 979-982. doi:10.3760/cma.j.cn511374-20210804-00649. https://pubmed.ncbi.nlm.nih.gov/36082569/
6. Bayer, Marc, Boller, Sören, Ramamoothy, Senthilkumar, Boehm, Thomas, Grosschedl, Rudolf. 2022. Tnpo3 enables EBF1 function in conditions of antagonistic Notch signaling. In Genes & development, 36, 901-915. doi:10.1101/gad.349696.122. https://pubmed.ncbi.nlm.nih.gov/36167471/